Preclinical research advise that retatrutide may influence weight problems-affiliated most cancers progression. Within a review led by Marathe et al., retatrutide-induced weight loss decreased tumor engraftment, delayed tumor onset, and considerably attenuated tumor progress in pancreatic and lung most cancers styles, with greater tumor suppression